These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 37462780)

  • 1. A glycomic workflow for LC-MS/MS analysis of urine glycosaminoglycan biomarkers in mucopolysaccharidoses.
    Nilsson J; Persson A; Vorontsov E; Nikpour M; Noborn F; Larson G; Blomqvist M
    Glycoconj J; 2023 Oct; 40(5):523-540. PubMed ID: 37462780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A straightforward, quantitative ultra-performance liquid chromatography-tandem mass spectrometric method for heparan sulfate, dermatan sulfate and chondroitin sulfate in urine: an improved clinical screening test for the mucopolysaccharidoses.
    Zhang H; Wood T; Young SP; Millington DS
    Mol Genet Metab; 2015 Feb; 114(2):123-8. PubMed ID: 25458519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycosaminoglycans analysis in blood and urine of patients with mucopolysaccharidosis.
    Khan SA; Mason RW; Giugliani R; Orii K; Fukao T; Suzuki Y; Yamaguchi S; Kobayashi H; Orii T; Tomatsu S
    Mol Genet Metab; 2018 Sep; 125(1-2):44-52. PubMed ID: 29779903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantification of Glycosaminoglycans in Urine by Isotope-Dilution Liquid Chromatography-Electrospray Ionization Tandem Mass Spectrometry.
    Zhang H; Young SP; Millington DS
    Curr Protoc; 2023 Mar; 3(3):e701. PubMed ID: 36929617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A modified liquid chromatography/tandem mass spectrometry method for predominant disaccharide units of urinary glycosaminoglycans in patients with mucopolysaccharidoses.
    Chuang CK; Lin HY; Wang TJ; Tsai CC; Liu HL; Lin SP
    Orphanet J Rare Dis; 2014 Sep; 9():135. PubMed ID: 25178307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycosaminoglycan levels in dried blood spots of patients with mucopolysaccharidoses and mucolipidoses.
    Kubaski F; Suzuki Y; Orii K; Giugliani R; Church HJ; Mason RW; Dũng VC; Ngoc CT; Yamaguchi S; Kobayashi H; Girisha KM; Fukao T; Orii T; Tomatsu S
    Mol Genet Metab; 2017 Mar; 120(3):247-254. PubMed ID: 28065440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Newborn screening and diagnosis of mucopolysaccharidoses.
    Tomatsu S; Fujii T; Fukushi M; Oguma T; Shimada T; Maeda M; Kida K; Shibata Y; Futatsumori H; Montaño AM; Mason RW; Yamaguchi S; Suzuki Y; Orii T
    Mol Genet Metab; 2013; 110(1-2):42-53. PubMed ID: 23860310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Untargeted LC-HRMS metabolomics reveals candidate biomarkers for mucopolysaccharidoses.
    Torres CL; Scalco FB; de Oliveira MLC; Peake RWA; Garrett R
    Clin Chim Acta; 2023 Feb; 541():117250. PubMed ID: 36764508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel heparan sulfate assay by using automated high-throughput mass spectrometry: Application to monitoring and screening for mucopolysaccharidoses.
    Shimada T; Kelly J; LaMarr WA; van Vlies N; Yasuda E; Mason RW; Mackenzie W; Kubaski F; Giugliani R; Chinen Y; Yamaguchi S; Suzuki Y; Orii KE; Fukao T; Orii T; Tomatsu S
    Mol Genet Metab; 2014; 113(1-2):92-9. PubMed ID: 25092413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. UPLC-MS/MS detection of disaccharides derived from glycosaminoglycans as biomarkers of mucopolysaccharidoses.
    Auray-Blais C; Lavoie P; Tomatsu S; Valayannopoulos V; Mitchell JJ; Raiman J; Beaudoin M; Maranda B; Clarke JT
    Anal Chim Acta; 2016 Sep; 936():139-48. PubMed ID: 27566349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous, non-reducing end glycosaminoglycan biomarkers are superior to internal disaccharide glycosaminoglycan biomarkers for newborn screening of mucopolysaccharidoses and GM1 gangliosidosis.
    Herbst ZM; Hong X; Urdaneta L; Klein T; Waggoner C; Liao HC; Kubaski F; Giugliani R; Fuller M; Gelb MH
    Mol Genet Metab; 2023; 140(1-2):107632. PubMed ID: 37407323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Updated Confirmatory Diagnosis for Mucopolysaccharidoses in Taiwanese Infants and the Application of Gene Variants.
    Chuang CK; Tu YR; Lee CL; Lo YT; Chang YH; Liu MY; Liu HY; Chen HJ; Kao SM; Wang LY; Ho HJ; Lin HY; Lin SP
    Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Multiplex Assay for the Diagnosis of Mucopolysaccharidoses and Mucolipidoses.
    Langereis EJ; Wagemans T; Kulik W; Lefeber DJ; van Lenthe H; Oussoren E; van der Ploeg AT; Ruijter GJ; Wevers RA; Wijburg FA; van Vlies N
    PLoS One; 2015; 10(9):e0138622. PubMed ID: 26406883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary glycosaminoglycans as a potential biomarker for evaluating treatment efficacy in subjects with mucopolysaccharidoses.
    Kakkis E; Marsden D
    Mol Genet Metab; 2020 May; 130(1):7-15. PubMed ID: 32224020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantification of glycosaminoglycans in urine by isotope-dilution liquid chromatography-electrospray ionization tandem mass spectrometry.
    Zhang H; Young SP; Millington DS
    Curr Protoc Hum Genet; 2013; Chapter 17():Unit 17.12. PubMed ID: 23315926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of disaccharide compositions derived from dermatan sulfate and heparan sulfate in mucopolysaccharidoses and mucolipidoses II and III by tandem mass spectrometry.
    Tomatsu S; Montaño AM; Oguma T; Dung VC; Oikawa H; Gutiérrez ML; Yamaguchi S; Suzuki Y; Fukushi M; Barrera LA; Kida K; Kubota M; Orii T
    Mol Genet Metab; 2010 Feb; 99(2):124-31. PubMed ID: 19932038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An At-Risk Population Screening Program for Mucopolysaccharidoses by Measuring Urinary Glycosaminoglycans in Taiwan.
    Lin HY; Lee CL; Lo YT; Tu RY; Chang YH; Chang CY; Chiu PC; Chang TM; Tsai WH; Niu DM; Chuang CK; Lin SP
    Diagnostics (Basel); 2019 Oct; 9(4):. PubMed ID: 31590383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Normalization of glycosaminoglycan-derived disaccharides detected by tandem mass spectrometry assay for the diagnosis of mucopolysaccharidosis.
    Lin HY; Lo YT; Wang TJ; Huang SF; Tu RY; Chen TL; Lin SP; Chuang CK
    Sci Rep; 2019 Jul; 9(1):10755. PubMed ID: 31341247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenous, non-reducing end glycosaminoglycan biomarkers for the mucopolysaccharidoses: Accurate diagnosis and elimination of false positive newborn screening results.
    Saville JT; Herbst ZM; Gelb MH; Fuller M
    Mol Genet Metab; 2023 Nov; 140(3):107685. PubMed ID: 37604083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A selective screening program for the early detection of mucopolysaccharidosis: Results of the FIND project - a 2-year follow-up study.
    Colón C; Alvarez JV; Castaño C; Gutierrez-Solana LG; Marquez AM; O'Callaghan M; Sánchez-Valverde F; Yeste C; Couce ML
    Medicine (Baltimore); 2017 May; 96(19):e6887. PubMed ID: 28489793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.